This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_LIP_ORAL_PHARYNX_NAS_EXALLC for full statistics.
Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx
C3_LIP_ORAL_PHARYNX_NAS
hypopharynx cancer: A primary or metastatic malignant neoplasm that affects the hypopharynx.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
33 |
4. Check minimum number of eventsNone |
33 |
5. Include endpointsNone |
33 |
6. Filter based on genotype QC (FinnGen only) |
33 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of head and neck
- Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
Similar with less cases:
None
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 33 | 5 | 28 |
| Unadjusted period prevalence (%) | 0.01 | 0.00 | 0.01 |
| Median age at first event (years) | 68.71 | 71.45 | 68.22 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
15
21
12.26
11.16
1.5
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
22
118
3.59
3.00
5.0
4.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
24
145
3.39
2.76
16.2
12.3
e9/l
4.4
4.6
0.20
24
126
(40768804) Tissue Pathology biopsy report
18
97
2.88
2.24
2.7
2.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
16
85
2.71
2.00
2.7
2.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
7
32
2.50
1.16
1.3
1.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
6
28
2.39
0.97
8.3
13.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
11
65
2.04
0.97
1.3
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
0
25
0.00
0.83
0.0
1.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
13
86
1.84
0.82
7.5
6.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
11
69
1.89
0.81
2.5
2.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
5
25
2.17
0.76
1.0
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
8
48
1.88
0.70
6.1
7.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
8
50
1.79
0.68
1.0
1.7
—
—
—
0
0
(3012544) pH of Venous blood
5
29
1.85
0.66
1.4
2.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
6
39
1.66
0.56
1.2
1.8
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
16
124
1.56
0.53
6.3
7.3
e9/l
1.7
1.8
0.09
16
107
(3023368) Bacteria identified in Blood by Culture
11
79
1.59
0.49
4.5
5.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
23
196
1.57
0.48
15.0
8.7
u/l
66.5
77.9
2.51
23
187
(3037467) Urinalysis macro (dipstick) panel - Urine
14
173
0.67
0.44
4.6
3.4
—
—
—
0
0
(3002256) Pathology report gross observation
5
34
1.55
0.42
1.2
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
0
15
0.00
0.42
0.0
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
15
0.00
0.42
0.0
1.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
5
75
0.61
0.42
2.8
3.1
mmol/l
5.8
7.4
—
5
64
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
6
41
1.56
0.39
1.2
2.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
8
104
0.70
0.36
4.3
3.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
7
52
1.44
0.34
1.6
2.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
5
70
0.66
0.30
3.6
2.3
—
—
—
0
0
(3013512) EKG study
10
81
1.34
0.22
2.6
3.7
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
11
0.00
0.22
0.0
1.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
0
10
0.00
0.22
0.0
2.8
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
0
12
0.00
0.21
0.0
3.2
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.8
—
38.8
—
0
12
(3013139) Helicobacter pylori Ag [Presence] in Stool
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
7
58
1.26
0.20
1.7
1.8
nmol/l
24.1
21.5
—
7
49
(3033658) Prothrombin time (PT) actual/Normal
5
65
0.73
0.19
4.8
4.3
%
69.6
86.4
—
5
65
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
12
102
1.28
0.18
2.6
3.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
8
70
1.19
0.18
10.8
7.9
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
10
118
0.78
0.18
1.8
3.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
9
79
1.19
0.17
2.6
2.8
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
18
166
1.19
0.11
5.7
3.6
pmol/l
14.2
15.3
1.00
18
151
(3020564) Creatinine [Moles/volume] in Serum or Plasma
26
267
0.88
0.09
32.6
19.4
umol/l
76.4
82.5
0.81
26
267
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
7
83
0.80
0.08
2.1
2.2
nmol/l
90.9
72.5
—
7
77
(3044889) 12 lead EKG panel
20
190
1.13
0.06
5.1
4.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
13
139
0.89
0.04
3.8
3.9
%
20.6
20.9
—
8
71
(3003338) MCHC [Mass/volume]
20
206
0.93
0.01
29.6
22.2
g/l
333.6
333.5
0.03
20
206
(3009542) Hematocrit [Volume Fraction] of Blood
21
208
1.03
0.00
22.4
19.0
%
40.3
39.9
0.11
11
149
(3011397) Hemoglobin [Presence] in Urine by Test strip
6
62
0.96
0.00
3.0
4.0
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
8
0.00
0.00
0.0
1.8
—
106.6
—
0
8
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4094501)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
0
8
0.00
0.00
0.0
1.0
—
0.0
—
0
8
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.0
—
0.0
—
0
9
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
0
6
0.00
0.00
0.0
1.3
—
28.8
—
0
6
(3019832) Treponema pallidum Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
8
0.00
0.00
0.0
1.8
—
4.3
—
0
8
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
0
8
0.00
0.00
0.0
1.0
—
0.0
—
0
8
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
5
0.00
0.00
0.0
4.4
—
—
—
0
0
(44790048)
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
0.2
—
0
5
(42529406) Shigella sp [Presence] in Stool by Culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
0
5
0.00
0.00
0.0
5.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
7
68
1.04
0.00
2.6
2.8
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(44790049)
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
8
87
0.89
0.00
2.4
3.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(44806118)
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44790047)
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
26
258
1.04
0.00
25.4
14.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
510.4
—
0
5
(3009214) Lutropin [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
5.9
—
0
7
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
1.2
—
0
5
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
7
0.00
0.00
0.0
3.7
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_LIP_ORAL_PHARYNX_NAS – Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).